Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTALK.L Regulatory News (TALK)

  • There is currently no data for TALK

Form 8.3 - TalkTalk Telecom Group plc

16 Oct 2020 13:37

Norges Bank - Form 8.3 - TalkTalk Telecom Group plc

Norges Bank - Form 8.3 - TalkTalk Telecom Group plc

PR Newswire

London, October 16

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeTalkTalk Telecom Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureDealing disclosure 15/10/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No Not required

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.1p ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:19,134,8851.67 %
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:19,134,8851.67 %

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Purchases and sales
Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
0.1p ordinarySale201,715GBP 0.98
GB00B4YCDF59

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:16/10/2020
Contact name:Stanislav Boiadjiev
Telephone number:+47 2407 3000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
15th Nov 20177:00 amRNSHalf Yearly Report
7th Nov 20172:04 pmRNSHolding(s) in Company
10th Oct 20173:48 pmRNSLong Term Incentive Awards
15th Sep 201710:52 amRNSDirectorate Change
4th Aug 201710:29 amRNSHolding(s) in Company
20th Jul 20171:48 pmRNSLong Term Incentive Awards
19th Jul 201712:41 pmRNSResult of AGM
19th Jul 20177:00 amRNSTrading Statement
10th Jul 20177:00 amRNSDirectorate Change
28th Jun 201712:56 pmRNSDirector/PDMR Shareholding
21st Jun 201710:03 amRNSPublication of Annual Report 2017 & Notice of AGM
14th Jun 201710:44 amRNSPublication of Annual Report 2017 & Notice of AGM
24th May 201710:01 amRNSHolding(s) in Company
18th May 20179:38 amRNSHolding(s) in Company
11th May 20173:28 pmRNSDirector/PDMR Shareholding
11th May 20173:27 pmRNSDirector/PDMR Shareholding
10th May 20177:00 amRNSFinal Results
6th Apr 20172:20 pmRNSHolding(s) in Company
3rd Apr 20172:58 pmRNSBond Listing
17th Mar 20172:48 pmRNSChange in Director's Particulars (LR 9.6.14(2))
1st Feb 20177:00 amRNSDirectorate Change
1st Feb 20177:00 amRNSQ3 Trading Statement
12th Jan 20173:29 pmRNSUpsizing and Pricing of £400 million Senior Notes
9th Jan 20178:40 amRNSProposed offering of £300 million Senior Notes
6th Jan 20174:52 pmRNSHolding(s) in Company
30th Nov 20161:30 pmRNSDirector/PDMR Shareholding
30th Nov 20161:30 pmRNSDirector/PDMR Shareholding
21st Nov 201610:17 amRNSHolding(s) in Company
16th Nov 20165:13 pmRNSDirector/PDMR Shareholding
15th Nov 20167:00 amRNSHalf Yearly Report
15th Sep 20169:03 amRNSHolding(s) in Company
16th Aug 201612:38 pmRNSDirector/PDMR Shareholding
16th Aug 201612:15 pmRNSDirector/PDMR Shareholding
4th Aug 20162:57 pmRNSDirector/PDMR Shareholding
1st Aug 20167:00 amRNSDirectorate Change
20th Jul 201612:10 pmRNSResult of AGM
20th Jul 201611:23 amRNSDirector/PDMR Shareholding
20th Jul 201611:21 amRNSDirector/PDMR Shareholding
20th Jul 201611:05 amRNSDirectorate Change
20th Jul 20167:00 amRNSTrading Statement
20th Jun 20167:07 amRNSAnnual Financial Report
16th Jun 20163:23 pmRNSDirector/PDMR Shareholding
16th Jun 20163:21 pmRNSDirector/PDMR Shareholding
7th Jun 20169:37 amRNSHolding(s) in Company
23rd May 20163:29 pmRNSLong Term Incentive Awards
23rd May 201612:00 pmRNSDirector/PDMR Shareholding
23rd May 201612:00 pmRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSFinal Results
14th Apr 20165:02 pmRNSDirector/PDMR Shareholding
14th Apr 20165:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.